BibTex format
@inproceedings{Leleu:2021:10.1200/JCO.2021.39.15_suppl.8024,
author = {Leleu, X and Mateos, M-V and Jagannath, S and Delimpasi, S and Simonova, M and Spicka, I and Pour, L and Kriachok, I and Gavriatopoulou, M and Dimopoulos, MA and Pylypenko, H and Auner, HW and Reuben, B and Venner, CP and Garg, M and DeCastro, A and Shah, JJ and Grosicki, S and Richardson, PG},
doi = {10.1200/JCO.2021.39.15_suppl.8024},
publisher = {LIPPINCOTT WILLIAMS & WILKINS},
title = {Effects of refractory status to lenalidomide on safety and efficacy of selinexor, bortezomib, and dexamethasone (XVd) versus bortezomib and dexamethasone (Vd) in patients with previously treated multiple myeloma.},
url = {http://dx.doi.org/10.1200/JCO.2021.39.15_suppl.8024},
year = {2021}
}